![Shao Lee Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shao Lee Lin
Directeur Général chez
CUE BIOPHARMA, INC.
Fortune : 7 M $ au 31/05/2026
Profil
Shao Lee Lin was the founder of ACELYRIN, Inc., founded in 2020, serving as Chief Executive Officer & Director from 2020 to 2024.
Current jobs include President, CEO, CFO & Director at Cue Biopharma, Inc. since 2026, and Director at Surrozen Operating, Inc. since 2021.
Former jobs include Director at Principia Biopharma, Inc. from 2019 to 2020; Independent Director at Surrozen, Inc. from 2021 to 2026; Independent Director at Third Harmonic Bio, Inc. from 2020 to 2023; VP-Inflammation & Respiratory Development at Gilead Sciences, Inc. from 2012 to 2015; VP-Therapeutic Areas & Development Excellence at AbbVie, Inc. from 2015 to 2017; Chief Scientific Officer, EVP, Head-R&D at Horizon Therapeutics Ltd. (Ireland) from 2018 to 2020; and Trustee at Lake Forest College from 2018 to 2020.
Education includes undergraduate studies at William Marsh Rice University and a doctorate from The Johns Hopkins University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 8,1 % | 01/06/2026 | 327 537 ( 8,1 % ) | 7 M $ | 31/05/2026 |
SURROZEN INC 0,02 % | 14/05/2025 | 2 341 ( 0,02 % ) | 61 358 $ | 31/05/2026 |
Postes actifs de Shao Lee Lin
| Sociétés | Poste | Début |
|---|---|---|
| CUE BIOPHARMA, INC. | Directeur Général | 30/04/2026 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Directeur/Membre du Conseil | 02/02/2021 |
Anciens postes connus de Shao Lee Lin
| Sociétés | Poste | Fin |
|---|---|---|
| SURROZEN, INC. | Directeur/Membre du Conseil | 26/01/2026 |
| ACELYRIN, INC. | Fondateur | 08/05/2024 |
| THIRD HARMONIC BIO, INC. | Directeur/Membre du Conseil | 17/01/2023 |
| PRINCIPIA BIOPHARMA INC. | Directeur/Membre du Conseil | 28/09/2020 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Directeur Technique/Scientifique/R&D | 23/01/2020 |
Formation de Shao Lee Lin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lake Forest College
 Lake Forest College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
